Review: Conditions causing weak expression of Kell system antigens

Immunohematology

Volumn 13, Issue 3, 1997, Pages 75-79

  Oyen R ^a   Halverson, G R ^a   Reid, M E ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

KEL gene; Kell system; Weakened Kell antigens

Indexed keywords

ANTIBODY;

ANTIBODY DETECTION; ANTIGEN EXPRESSION; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD GROUP KELL SYSTEM; CHRONIC GRANULOMATOUS DISEASE; ERYTHROCYTE; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0030845253     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Coombs RRA, Mourant AE, Race RR. In-vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1946;i:264-6.
2. Daniels GL, Anstee DJ, Cartron J-P, et al. Blood group terminology 1995. From the ISBT working party on terminology for red cell surface antigens. Vox Sang 1995;69:265-79.
3. Marsh WL, Redman CM. The Kell blood group system: a review. Transfusion 1990;30:158-67.
4. Lee S, Wu X, Reid ME, Zelinski T, Redman C. Molecular basis of the Kell (K1) phenotype. Blood 1995;85:912-6.
5. Lee S, Wu X, Reid ME, Redman C. Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system. Transfusion 1995;35:822-5.
6. Lee S, Wu X, Son S, et al. Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles. Transfusion 1996;36:490-4.
7. Advani H, Zamor J, Judd WJ, Johnson CL, Marsh WL. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide. Br J Haematol 1982;51:107-15.
8. a) blood group antigen integrity (abstract). Transfusion 1982;22:420.
9. b, a new antibody in the Kell blood group system. Vox Sang 1958;3:1-13.
10. Tippett P. Expansion of the Lutheran and Kell blood group systems. In; Mohn JF, Plunkett RW, Cunningham RK, Lambert RM, eds. Human blood groups. Basel, Karger, 1977:401-9.
11. 0 exhibiting depression of some Kell group antigens. Vox Sang 1977;32:220-3.
12. Marsh WL, Jensen L, Øyen R, et al. Anti-K13 and the K:-13 phenotype. A blood-group variant related to the Kell system. Vox Sang 1974;26;34-40.
13. Kaita H, Lewis M, Chown B, Gard E. A further example of the Kell blood group phenotype K-, k-, Kp(a-b-). Nature 1959;183:1586.
14. o. Vox Sang 1966;11:611-9.
15. Marsh WL, Øyen R, Nichols ME, Allen FH Jr. Chronic granulomatous disease and the Kell blood groups. Br J Haematol 1975;29:247-62.
16. Marsh WL, Redman CM. Recent developments in the Kell blood group system. Transfus Med Rev 1987; 1:4-20.
17. Peloquin P, Yochum G, Hagy L, Øyen R, Johnson C. The Mullins phenotype: another RBC phenotype characterized by weak Kell antigens (abstract). Transfusion 1988;28(Suppl): 19S.
18. Brown A, Berger R, Lasko D, et al. The Day phenotype: a "new" variant in the Kell blood group system. Revue Française de Transfusion et Immuno-hématologie 1982;25:619-27.
19. Marsh WL, Schnipper EF, Johnson CL, Mueller KA, Schwartz SA. An individual with McLeod syndrome and the Kell blood group antigen K(K1). Transfusion 1983;23:336-8.
20. White W, Washington ED, Sabo BH, et al. Anti-Km in a transfused man with McLeod syndrome. Revue Française de Transfusion et Immuno-hématologie 1980;23:305-17.
21. Øyen R, Reid ME, Rubinstein P, Ralph H. A method to detect McLeod phenotype red blood cells. Immunohematology 1996;12:160-3.
22. Arndt P, Garratty G, Raghunathan R. Use of flow cytometry for quantitation of mixed RBC populations in female carriers of the McLeod gene (abstract). Transfusion 1994;34(Suppl);21S.
23. Daniels GL, Weinauer F, Stone C, et al. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells. Blood 1996;88:4045-50.
24. Race RR, Sanger R. Blood groups in man. Oxford, England: Blackwell Scientific Publications, 1975.
25. Reid ME. The Gerbich blood group antigens: a review, Med Lab Sci 1986;43:177-82.
26. Daniels GL. Studies on Gerbich negative phenotypes and Gerbich antibodies (abstract). Transfusion 1982;22:405.
27. Anstee DJ, Ridgwell K, Tanner MJ, Daniels GL, Parsons SF. Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins beta and gamma. Biochem J 1984;221:97-104.
28. Reid ME, Anstee DJ, Tanner MJ, Ridgwell K, Nurse GT. Structural relationships between human erythrocyte sialoglycoproteins beta and gamma and abnormal sialoglycoproteins found in certain rare human erythrocyte variants lacking the Gerbich blood-group antigen(s). Biochem J 1987;244:123-8.
29. Reid ME. Biochemistry and molecular cloning analysis of human red cell sialoglycoproteins that carry Gerbich blood group antigens. In: Unger P, Laird-Fryer B, eds. Blood group systems: MNSsU, Gerbich and glycoproteins. Arlington, VA: American Association of Blood Banks, 1989:73-103.
30. Anstee DJ. Blood group active surface molecules of the human red blood cell. Vox Sang 1990;58:1-20.
31. Seyfreid H, Górska B, Maj S, Sylwestrowicz T, Giles CM, Goldsmith KLG. Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia. Vox Sang 1972;23:528-36.
32. Marsh WL, Øyen R, Alicea F, Linter M, Horton S. Autoimmune hemolytic anemia and the Kell blood groups. Am J Hematol 1979;7:155-62.
33. b associated with weakened antigenicity in the Kell blood group system: a second example. Transfusion 1979;19:197-202.
34. Williamson LM, Poole J, Redman C, et al. Transient loss of proteins carrying Kell and Lutheran red cell antigens during constructive relapses of autoimmune thrombocytopenia. Br J Haematol 1994;87:805-12.
35. Marsh WL, DiNapoli J, Øyen R. Auto-immune hemolytic anemia caused by anti-K13. Vox Sang 1979;36:174-8.
36. b in a Kp(a+b-) patient. Vox Sang 1983;45;252-6.